AusPAR: Keytruda

Australian Public Assessment Report

AusPAR

AusPAR: Keytruda [PDF, 1.22 MB]

AusPAR: Keytruda [Word, 2.12 MB]

AusPAR Attachment 1: Product Information for Keytruda [PDF, 1.75 MB]

AusPAR Attachment 1: Product Information for Keytruda [Word, 1.81 MB]

Device/Product Name

Keytruda

Active ingredients

Pembrolizumab

AusPAR Date

23 June 2023

Published

27 June 2023

Submission Number

PM-2020-06395-1-4

Submission Type

Extension of indication

Decision

Approved